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PREAMBLE 
It was during the 4th year’s teaching course, given by Dr. Reto Agosti at the University of 
Zurich, when I discovered my interest for neurology, and especially headaches. So I 
started my doctoral thesis at the Headache and Pain Clinic (HPC) at the Department of 
Neurology. I not only had the opportunity to collect and analyze data of a few hundreds of 
headache patients, but also to benefit from the experience of the founder of the HPC and 
first president of the Swiss Headache Society, Dr. Hansruedi Isler. It was then a great 
success for me as a student, when I won an award for the best poster at the World 
Headache Conference in London in 2000. This was furthermore highly stimulating to 
continue a career combining clinical work and research.  
Due to my mentor and greatly appreciated colleague PD Dr. Peter Sándor, who introduced 
me to Prof. Peter Goadsby and Dr. Holger Kaube, I started as a research fellow at the 
Headache Group, Institute of Neurology, Queen Square in London, shortly after I passed 
my state examination. In the following two years I had the great possibility to learn clinical 
skills from two headache experts, and to benefit from a melting pot of rare headache 
syndromes at the National Hospital for Neurology and Neurosurgery. Research-wise we 
started an electrophysiological project to gain more insights into migraine pathophysiology. 
We used photic stimulation techniques and evoked potential recording to investigate the 
early phase of migraine in comparison to healthy volunteers. 
Back in Switzerland I started my clinical training in neurology, where I also had to 
experience the difficulties of combining clinical duties, family life, and research. After 3 
years of basic training at RehaClinic Bad Zurzach and at the Cantonal Hospital Aarau, I 
continued at the department of Neurology, University Hospital Zurich. In May 2010 I was 
appointed to lead the HPC, as an ‘Oberarzt’. In this quite small research team of only 3 to 
5 collaborators, our group published more than 20 peer-reviewed publications in the field 
of headaches from 2008 onwards (12 with own contribution). 
 
Since July 2012 I’ve been working as a ‘Leitender Arzt’ at the Neurorehabilitation Center 
RehaClinic Bad Zurzach, where we also provide an inpatient program for medication 
overuse headache, chronic migraine, and posttraumatic headaches. I am still collaborating 
with colleagues from the University Hospital Zurich (Headache and Pain Clinic at the  
Department of Neurology (lead  PD Dr. A. Palla); Department of Neurosurgery; Ambulatory 
Pain Clinic; and Division of Cranio-Maxillo-Facial and Oral Surgery) to provide access to 
neuromodulation for patients with chronic and treatment-refractory headaches. 
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SUMMARY 
Headaches are not only among the top causes why patients seek help from doctors; they 
also have a high socio-economic impact. The International Headache Society has 
classified more than 250 different headache types, whereof tension type headache and 
migraine account for the most frequent ones. While many patients never see a doctor 
because of their headaches, and numerous are treated in primary care, some patients 
need help from a headache specialist and will be referred to a headache center. They 
might suffer from a rare type of headache, the headache might have deteriorated, or it 
might be refractory to treatment. 
 
The Headache and Pain Clinic (HPC, Kopfwehsprechstunde) was founded at the 
Department of Neurology, University Hospital Zurich in 1966. Since then it remained a 
tertiary care center for the assessment and management of difficult to treat headache 
problems, which often requires multimodality and interdisciplinarity. Since its foundation it 
was also a main goal to improve collaboration with primary care. In study A we described 
the characteristics of the population of headache patients at the HPC. Most patients were 
diagnosed with migraine or a combination of migraine and tension type headaches. The 
coexistence of migraine and tension type headache, as well as the high frequency of 
headache days would have excluded most migraine patients from typical drug trials: at 
best, only one third of the tertiary care population would be eligible. This demonstrates 
some limits of evidence-based medicine for a subpopulation of highly affected patients. 
In study B we compared two samples of patients from primary and tertiary care. The 
differences in management strategies mainly reflected differences in headache severity 
and chronicity. The shortcomings of diagnosis and treatment in primary care seemed to be 
minimized by the involvement in such an investigation. The awareness of headache in 
primary care was the focus of study C. In cooperation with the Swiss Headache Society 
we conducted a survey about the frequency of headache patients in GP practices and 
inquired about their treatment and referral strategies. General practitioners provide first 
access for most undiagnosed headache patients. Therefore efficient and correct diagnosis 
and management is eminent, especially when patients have to be referred for further 
evaluation. Both patients and physicians may benefit from a well-functioning ‘bidisciplinary’ 
cooperation. 
 
As an advantage, a tertiary headache centers may function like a melting pot for rare 
headaches disorders. For instance, the largest series of SUNCT, a rare neuralgiform 
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autonomic headache, comes from the Headache Group, Institute of Neurology, Queen 
Square in London, UK. In study D we describe a series of patients with orofacial cluster 
headache, a form of cluster headache with an atypical localization, which is usually first 
seen in the dental practice. Thus, the series was published in cooperation with colleagues 
from the dental hospital, University Zurich. In study E we described adults with acute 
confusional migraine, again in cooperation with colleagues from other headache centers 
and from secondary care. Acute confusional migraine is most probably a subtype of 
migraine with aura which can typically be seen in children and adolescents. In adults the 
differential diagnosis to more hazardous diseases, like stroke or epilepsy, may be 
challenging. 
 
Finally, a headache center is not only a predisposed partner for randomized-controlled 
multicenter trials, there is also room for clinical field-testing or even development of new 
treatment options in a multidisciplinary setting. In study F we described the largest series 
of steroid injections of the greater occipital nerve for the treatment of acute and chronic 
cluster headache. We were able to show that infiltration of the greater occipital nerve is a 
valuable and safe option in the clinical setting. In cooperation with the Department of 
Women’s Health we published retrospective data of 38 women with migraine (study G), 
who used a progestin-only pill for contraception. In these patients, migraine tended to 
improve in frequency and intensity. 
 
The present work highlights the elements of interdisciplinary headache care at the tertiary 
level: a good collaboration of all the different partners and specialists, keeping up-to-date 
with the latest treatment developments, and foremost being close to the patient. 
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INTRODUCTION 
 
In 1988 the International Headache Society has defined criteria for classification of 
headache disorders for the first time [1]. These criteria have been revised in 2004 [2] and 
the 3rd edition is expected in mid-2013. There are criteria for more than 250 headache 
disorders, whereof tension type headache, migraine and cluster headache account for the 
most frequent of all primary headaches. While tension type headaches do in general not 
interfere with daily activity, migraine may often be very disabling [3], and cluster headache 
even belongs to the most severe pain disorders. In 2001 the World Health Report ranked 
migraine among the 20 diseases with most years of life lived with disability [4]. Several 
studies of the last decades have highlighted the socio-economic impact of migraine (for a 
review see [5]). 
In a recent publication the European Headache Federation assessed the needs and 
demands for headache care and made a proposal for the organization of headache 
service in Europe [6]. Three different levels are described, primary care, special-interest 
care and headache centers, with an advanced multidisciplinary setting. It is self-evident 
that most headache patients are being treated in primary care. However, for difficult-to-
treat headache disorders and rare headache types, secondary, but also tertiary headache 
care providers are important. The Headache and Pain Clinic (Kopfwehsprechstunde) at 
the Department of Neurology at University Hospital Zurich, was established in 1966. Since 
then it remained a service for the assessment and management of difficult headache 
problems. Patients usually are referred by general practitioners and specialists. Most 
patients have been treated unsuccessfully by several physicians and laymen before. They 
often require time-consuming and individualized care, in a multimodal and interdisciplinary 
setting. 
 
In this cumulative habilitation I will describe the Headache and Pain Clinic at the University 
Hospital of Zurich [A,B]. I will demonstrate the value of a good cooperation with general 
practice [B,C]. Furthermore I will highlight the benefits of a tertiary headache center in 
respect of generating clinical implications by two examples of rare headache disorders 
[D,E] and the development and clinical testing of new treatments options [7-9,F,G]. By 
those means I want to provide strong arguments for the importance of interdisciplinary and 
headache care at tertiary level. 
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ABSTRACTS OF INCLUDED PUBLICATIONS 
 
Study A: Nosology and treatment of primary headache in a Swiss Headache clinic. 
Methods. Retrospective description of all patients with migraine, tension type headache 
and combinations of migraine and tension type headache who were seen at the headache 
and pain clinic, Department of Neurology, University Hospital Zurich, in the years 1996 to 
1998 (n=1625). Demographical and clinical data, drugs, physical and alternative 
treatments before and after referral were collected. Descriptive statistics were used for 
differences between the sample, headache subtypes and the general population. 
Results. According to the IHS criteria the patients were diagnosed with migraine in 47.3%, 
with tension type headaches in 20%, and in 32.7% with a combination of both (see also 
figure 1). On average migraine patients had a lower frequency of headache days per 
month than tension type headache patients. The most frequent special investigations 
were: CT scan (18.2% before, 7.6% after first consultation), EEG (10% before, 2.3% after 
first consultation) and MRI (5.5% before, 3.8% after first consultation). No pathology was 
found which would have led to further interventions. The most frequently reported 
complementary treatments were acupuncture (n=338) and homeopathy (n=120), while all 
other methods were reported by small minorities. 
Conclusion. The coexistence of migraine and tension type headache, and the high 
frequencies of headache days would have excluded most migraine patients from typical 
drug trials: at best, only one third were eligible. The socioeconomic impact of combined 
and difficult headache syndromes calls for comprehensive management. 
 
Figure 1. More than one half of the migraine patients was referred as migraine but only one sixth of the 
tension type headaches, and one tenth of the combined headaches came in with a correct diagnosis. Most of 
the headaches have been referred as “unspecific headache”. 
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Study B: Headache patients in primary care and a tertiary care unit in Zürich, 
Switzerland. 
Methods. Demographic features, severity of disorders, and medical management were 
compared between primary and tertiary care. Case-control study with data from 181 
randomly selected patients at the headache and pain clinic (HPC), Department of 
Neurology, University Hospital Zurich, and 181 patients from 20 general practitioners (GP) 
from the region of Zurich.  
Results. There was a predominance of women and socially underprivileged individuals in 
both samples. Chronic headache was overrepresented in the HPC (44.7%). Loss of work 
above two months was found exclusively in the HPC (9.9%). In the GP sample 89.5% 
were using attack treatment, and 59.7% were treated with prophylactics. In the HPC 
90.6% took acute drungs and 67.4% were on a preventive. One third of both groups had 
had complementary and alternative medical treatment. 
Conclusion. Differences in management strategies reflected differences in headache 
severity and chronicity. Results indicated that remaining shortcomings of diagnosis and 
treatment of headache in primary care could be minimized by involving GPs in similar non-
commercial studies. 
 
Study C: Awareness of Headache and of National Headache Society Activities 
among Primary Care Physicians - a qualitative study. 
Methods. In a qualitative telephone survey, targeting primary care practices, we asked 
about the frequency of headache patients in their practices and inquired about their 
treatment and referral strategies. 
Results. A total of 1000 telephone interviews with primary care practices were conducted. 
Three-hundred and fifty physicians were directly interviewed, 95% of them see headache 
patients every week, 23% daily. Direct MRI referral was done by 84%. Sixty-two per cent 
of the physicians knew the Swiss headache society, 73% were interested in further 
education about headaches. 
Conclusion. The survey yielded information about the physicians' awareness of the Swiss 
Headache Society and its activities, and about their desire for continuing education in the 
area of headache. National headache societies should work to improve the cooperation 
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Study D: Orofacial cluster headache. 
Methods. Case series of patients who fulfill diagnostic criteria for cluster headache, but 
experience excruciating pain - rather than headache - in the distribution of the 2nd or 3rd 
trigeminal divisions.  
Conclusion. Lacking a diagnostic concept, these patients tend to receive inadequate 
medical and dental treatment, including multiple tooth extractions. We review similar cases 
in the literature and discuss a possible extension of the localisation criteria for cluster 
headache. 
 
Study E: Confusional migraine is an adult as well as a childhood disease.  
Methods. Acute confusional migraine is considered a rare migraine variant primarily seen 
in children and adolescents. Case series of eight adults and two adolescents suffering 
from migraine attacks associated with transient confusional states. 
Results. Eight patients reported two or more such attacks. One of them reported mild head 
trauma in the past. One patient reported mild head trauma as a possible trigger. Further 
investigations were unremarkable in all patients and did not suggest underlying structural 
abnormalities.  
Conclusion. Our findings propose expanding the concept of confusional migraine from the 
pediatric population to adults. The temporal course of the confusion as well as the 
association with visual and other aura symptoms suggest cortical spreading depression as 
the underlying pathophysiology. 
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Study F: Efficacy and safety of 121 injections of the greater occipital nerve (GON) in 
episodic and chronic cluster headache. 
Methods. Retrospective analysis of efficacy and safety of 121 injections of the greater 
occipital nerve in 60 consecutive patients with episodic or chronic cluster headache, over a 
period of 4 years. 
Results. Almost 80% of the infiltrations were at least partially effective (reduction of attack 
frequency, duration or severity) and 45% resulted in a complete response (no further 
attacks). The effect was maintained for a median of 14 days in chronic cluster headache, 
and 25 days in episodic cluster headache. In 18 infiltrations (=14.2%), transient side 
effects were reported, such as local pain, steroid effects, or syncope. 
Conclusion. The data show that infiltration of the greater occipital nerve is a valuable and 
safe option in the clinical setting to treat patients suffering from cluster headache, 
especially for the episodic form. 
 
Figure 2. Bilateral versus unilateral infiltrations in patients with chronic cluster headache, indicating better 
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Study G: Headache frequency and intensity in female migraineurs using 
desogestrel-only contraception: A retrospective pilot diary study.  
Methods. A retrospective diary study of women with migraine, who used desogestrel 75µg 
as an oral contraceptive. Out of 58 women, 38 had completed headache diaries for a 
period of 6 months. Incomplete diaries (n=12), side effects (n=5), and loss to follow-up 
(n=3), were the reasons for the exclusion of 20 subjects. The 90 days before (baseline) 
and after (on oral contraception) initiation of the progestin were compared. 
Results. Days with migraine, days with all kind of headache, and days with use of any 
headache medication, were significantly reduced at follow-up after three months. In 
addition there was a reduction in headache intensity (p<0.0001). The reduction in number 
of days with use of triptans was not significant (p<0.14). 
Conclusion. Our data indicate that the progestin-only pill desogestrel 75µg in addition to 
providing efficient contraception tends to improve migraine frequency and intensity in 
female migraineurs. Because of the limitations of our study with regard to sample size and 
design as an observational investigation, these results are at too early a stage to draw 
definite conclusions.  
 
 
Figure 3. Individual patient data for absolute change in migraine and headache days after 90 days of 
treatment with desogestrel 75 µg. 
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COMMENTARY 
 
In study A we described the characteristics of the Headache and Pain Clinic 
(Kopfwehsprechstunde), a typical tertiary headache care unit. We know that difficult-to-
treat headache problems may cumulate in such centers. However, there are only a few 
studies describing the population of headache patients in tertiary care. In contrary to the 
general population, where tension type headache is the most prevalent headache type 
[10], most patients in tertiary care suffer from migraine [11,12]. The coexistence of 
migraine and tension type headache, as well as the high frequency of headache days 
would have excluded most migraine patients from typical drug trials [13]: at best, only one 
third of the tertiary care population would be eligible. This is an additional demonstration of 
the complexity of tertiary headache care, and depicts some limitations of evidence-based 
medicine, as there is almost no evidence for how to treat rare or complex medical 
problems [14]. Two further publications with own contribution may support this statement, 
potential treatment options for orgasmic headache [15], or episodic cluster headache [16]. 
On the whole, multidisciplinary headache management becomes crucial [17]. 
 
In study B we compared a sample of patients from tertiary care with patients in general 
practice. Most differences were explained by differences in headache severity and 
chronicity. However, the results also indicated that remaining shortcomings of diagnosis 
[18,19] and treatment of headache in primary care could be minimized by involving GPs in 
such non-commercial studies. Only recently, the International Headache Society initiated a 
Primary Care Interest Group for the improvement of the clinical management of migraine 
and headache [20]. The same author encouraged research into headache in primary care 
[20]. In a pioneer survey of the Swiss Headache Society we were investigating the 
awareness of headache among general practitioners. As study C shows, almost ¼ of the 
general practitioners see headache patients every day. More than sixty per cent knew the 
Swiss headache society, and almost ¾ were interested in education about headaches. A 
large percentage of primary care physicians directly ordered MRI scans. This was an 
unexpected finding, with possible implications for health-care costs. In the older study [B] 
the number was smaller. However, a recent study from the U.K. concluded that GPs who 
know the correct indications for MRI may appropriately select patients with headaches for 
neuroimaging [21], even with potential financial savings. 
 
As discussed above, there is not only an accumulation of complex, but also of rare 
headache disorders in tertiary headache centers. The largest series of SUNCT, a rare 
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neuralgiform autonomic headache, comes from the Headache Group, Institute of 
Neurology, Queen Square London, UK [22]. Also the first published familial SUNCT-
syndrome was from the outpatient clinic at Queen Square [23]. In study D we described a 
case series of orofacial cluster headache. This form of cluster headache presents with 
pain in the second or third trigeminal branch, and is typically first seen in the dental 
practice. From the collaboration with the colleagues from the dental hospital, University 
Zurich, there is another series with atypical presentation of migraine pain [24]. In study E 
we described a series of adults with acute confusional migraine. Most probably a subtype 
of migraine with aura, it is well known in children and adolescents [25,26]. Thus, when 
presenting in adults the differential diagnosis to hazardous diseases, like stroke or 
epilepsy, may be more difficult. 
 
Most multicenter randomized-controlled trials are conducted at large tertiary headache 
centers. The HPC was involved in some pivotal studies [7-9]. Publications F & G are two 
examples of uncontrolled studies with direct clinical implications. Study F is the largest 
series of steroid injections of the greater occipital nerve for the treatment of acute and 
chronic cluster headache. A French group published a randomized controlled trial with 43 
subjects using a slightly different protocol, supporting that suboccipital nerve blocks are a 
valuable and safe option in the treatment of cluster headache [27]. Study G is a 
retrospective pilot study of 38 women with migraine with and without aura, who used a 
progestin-only pill for contraception. While migraine seems substantially related to 
hormonal changes, not only migraine, but also the use of combined oral contraceptives, 
are associated with an increased risk for vascular events [28]. Therefore progestagen-only 
contraception is an alternative, which was first studied by an Italian group in migraine with 
aura [29]. Their pilot study showed a reduction of migraine attacks and of the duration of 
visual auras. In our sample also women with migraine without aura had a benefit from the 
estrogen-free contraception.  
 
All the presented work highlights the elements of interdisciplinary headache care at the 
tertiary level. A good collaboration of all the different partners and specialists, keeping up-
to-date with the latest treatment developments, and foremost being close to the patient, 
should be the main goals.
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